loading

Eliem Therapeutics Inc (ELYM) 最新ニュース

pulisher
Feb 04, 2025

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Bought by JPMorgan Chase & Co. - Defense World

Feb 04, 2025
pulisher
Jan 22, 2025

Barclays PLC Acquires 36,316 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World

Jan 22, 2025
pulisher
Jan 16, 2025

Jane Street Group LLC Purchases New Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World

Jan 16, 2025
pulisher
Jan 13, 2025

Eliem Therapeutics Enters into Exclusive Licensing Agreement with Beijing Mabworks Biotech - Defense World

Jan 13, 2025
pulisher
Jan 02, 2025

State Street Corp Has $1.60 Million Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

Eliem Therapeutics stock hits 52-week low at $1.86 amid market shifts - Investing.com Australia

Dec 31, 2024
pulisher
Dec 30, 2024

Eliem Therapeutics stock hits 52-week low at $1.86 amid market shifts By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 28, 2024

Financial Analysis: TransCode Therapeutics (NASDAQ:RNAZ) & Eliem Therapeutics (NASDAQ:ELYM) - Defense World

Dec 28, 2024
pulisher
Dec 20, 2024

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Holdings Boosted by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Acquires Shares of 49,524 Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World

Dec 17, 2024
pulisher
Dec 10, 2024

590,946 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Point72 Asset Management L.P. - MarketBeat

Dec 10, 2024
pulisher
Dec 08, 2024

Janus Henderson Group PLC Has $18.30 Million Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Dec 08, 2024
pulisher
Dec 05, 2024

Samsara BioCapital LLC Has $13.28 Million Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Parkman Healthcare Partners LLC Takes Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Dec 04, 2024
pulisher
Nov 28, 2024

Ally Bridge Group NY LLC Purchases 729,292 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Nov 28, 2024
pulisher
Nov 27, 2024

Great Point Partners LLC Buys New Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Nov 27, 2024
pulisher
Nov 04, 2024

Eliem Therapeutics To Acquire Tenet Medicines - Contract Pharma

Nov 04, 2024
pulisher
Oct 18, 2024

How To Trade (CLYM) - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 11, 2024

Climb Bio to present kidney disease treatment study - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Climb Bio to present kidney disease treatment study By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 03, 2024

Eliem Therapeutics Inc [ELYM] Shares Fall -0.97 % on Wednesday - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Eliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs - FiercePharma

Oct 03, 2024
pulisher
Oct 02, 2024

Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases - Investing.com

Oct 02, 2024
pulisher
Oct 02, 2024

Eliem Therapeutics Changes Name to Climb Bio - Yahoo Finance

Oct 02, 2024
pulisher
Oct 02, 2024

Eliem Therapeutics to change corporate name to Climb Bio - TipRanks

Oct 02, 2024
pulisher
Oct 02, 2024

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - The Manila Times

Oct 02, 2024
pulisher
Oct 01, 2024

Healthy Upside Potential: Eliem Therapeutics Inc (ELYM) - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Monitoring Eliem Therapeutics Inc (ELYM) after recent insider movements - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Eliem Therapeutics Inc (ELYM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

Ratio Analysis: Unpacking Eliem Therapeutics Inc (ELYM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock Position Decreased by Driehaus Capital Management LLC - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St

Sep 29, 2024
pulisher
Sep 28, 2024

Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m - Yahoo Finance

Sep 28, 2024
pulisher
Sep 26, 2024

Eliem Therapeutics Inc (ELYM) can make a big difference with a little luck - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

Eliem Therapeutics Inc (ELYM) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Takes $11.88 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Trading (ELYM) With Integrated Risk Controls - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

500,000 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Ally Bridge Group NY LLC - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha

Sep 23, 2024
pulisher
Sep 23, 2024

Closing Figures: Eliem Therapeutics Inc (ELYM)’s Positive Finish at 8.43, Up 1.81 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Eliem Therapeutics Inc (ELYM)’s stock price in review: A technical analysis - US Post News

Sep 23, 2024
pulisher
Sep 21, 2024

Eliem therapeutics executive sells over $9,000 in company stock By Investing.com - Investing.com Australia

Sep 21, 2024
pulisher
Sep 20, 2024

Eliem therapeutics executive sells over $9,000 in company stock - Investing.com

Sep 20, 2024
pulisher
Sep 13, 2024

(ELYM) Trading Signals - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 11, 2024

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewswire

Sep 11, 2024
pulisher
Sep 06, 2024

Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6% - MarketBeat

Sep 06, 2024
$31.33
price up icon 0.35%
$19.94
price up icon 1.92%
$357.04
price up icon 1.54%
$4.57
price down icon 2.56%
biotechnology ONC
$225.78
price up icon 0.63%
$114.16
price down icon 1.09%
大文字化:     |  ボリューム (24 時間):